Literature DB >> 22263596

Toxicokinetics of naringin and its metabolite naringenin after 180-day repeated oral administration in beagle dogs assayed by a rapid resolution liquid chromatography/tandem mass spectrometric method.

Cui-Ping Yang1, Meng-Hua Liu, Wei Zou, Xiao-Ling Guan, Li Lai, Wei-Wei Su.   

Abstract

Toxicokinetic characteristics of naringin and its metabolite naringenin were investigated in beagle dogs after oral administration of naringin at the doses of 20, 100, or 500 mg/kg/day in a repeated-dose study for 1, 30, 90, and 180 days. Plasma concentrations of naringin and naringenin were determined by a rapid resolution liquid chromatography/electrospray ionization/tandem mass spectrometric method. The results showed that no differences in systemic exposure were observed between male and female beagle dogs. Systematic exposure exhibited dose-dependent increase for both naringin and naringenin. No significant accumulations were observed. Results would be taken into consideration for the interpretation of toxicology findings and provide a reference for clinical safety assessment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22263596     DOI: 10.1080/10286020.2011.632369

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  8 in total

Review 1.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

2.  Assessment of the feed additive consisting of naringin for all animal species for the renewal of its authorisation (HealthTech Bio Actives, S.L.U. (HTBA)).

Authors:  Vasileios Bampidis; Giovanna Azimonti; Maria de Lourdes Bastos; Henrik Christensen; Birgit Dusemund; Mojca Fašmon Durjava; Maryline Kouba; Marta López-Alonso; Secundino López Puente; Francesca Marcon; Baltasar Mayo; Alena Pechová; Mariana Petkova; Fernando Ramos; Yolanda Sanz; Roberto Edoardo Villa; Ruud Woutersen; Paul George Brantom; Johannes Westendorf; Jaume Galobart; Paola Manini; Fabiola Pizzo
Journal:  EFSA J       Date:  2022-04-22

Review 3.  Antioxidants in liver health.

Authors:  Sael Casas-Grajales; Pablo Muriel
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

4.  The development and validation of a sensitive HPLC-MS/MS method for the quantitative and pharmacokinetic study of the seven components of Buddleja lindleyana Fort.

Authors:  Xia Zhang; Zhi-Qing Zhang; Li-Cang Zhang; Ke-Xin Wang; Lan-Tong Zhang; De-Qiang Li
Journal:  RSC Adv       Date:  2021-07-28       Impact factor: 4.036

5.  Pharmacokinetic Analysis of an Oral Multicomponent Joint Dietary Supplement (Phycox®) in Dogs.

Authors:  Stephanie E Martinez; Ryan Lillico; Ted M Lakowski; Steven A Martinez; Neal M Davies
Journal:  Pharmaceutics       Date:  2017-08-18       Impact factor: 6.321

6.  Tissue Distribution of Total Flavonoids Extracts of Drynariae Rhizoma in Young and Old Rats by UPLC-MS/MS Determination.

Authors:  Yue Zhang; Xia Lei; Hongdan Xu; Guoliang Liu; Yeqiu Wang; Huifeng Sun; Fang Geng; Ning Zhang
Journal:  J Anal Methods Chem       Date:  2022-02-04       Impact factor: 2.193

7.  Identification of metabolites of liquiritin in rats by UHPLC-Q-TOF-MS/MS: metabolic profiling and pathway comparison in vitro and in vivo.

Authors:  Xia Zhang; Caijuan Liang; Jintuo Yin; Yupeng Sun; Lantong Zhang
Journal:  RSC Adv       Date:  2018-03-27       Impact factor: 3.361

8.  Safety and efficacy of a feed additive consisting of a flavonoid-rich dried extract of Citrus × aurantium L. fruit (bitter orange extract) for use in all animal species (FEFANA asbl).

Authors:  Vasileios Bampidis; Giovanna Azimonti; Maria de Lourdes Bastos; Henrik Christensen; Mojca Fašmon Durjava; Maryline Kouba; Marta López-Alonso; Secundino López Puente; Francesca Marcon; Baltasar Mayo; Alena Pechová; Mariana Petkova; Fernando Ramos; Yolanda Sanz; Roberto Edoardo Villa; Ruud Woutersen; Paul Brantom; Andrew Chesson; Johannes Westendorf; Paola Manini; Fabiola Pizzo; Birgit Dusemund
Journal:  EFSA J       Date:  2021-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.